Motus GI Holdings Inc (NASDAQ:MOTS) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 800,300 shares, an increase of 28.7% from the May 30th total of 621,900 shares. Approximately 5.6% of the shares of the company are sold short. Based on an average daily trading volume, of 137,700 shares, the days-to-cover ratio is presently 5.8 days.
In other Motus GI news, Chairman David P. Hochman purchased 10,000 shares of the company’s stock in a transaction dated Monday, July 1st. The shares were bought at an average price of $3.00 per share, with a total value of $30,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Life Sciences Maste Perceptive purchased 1,000,000 shares of the company’s stock in a transaction dated Thursday, June 27th. The shares were acquired at an average cost of $3.00 per share, for a total transaction of $3,000,000.00. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 2,059,332 shares of company stock valued at $6,179,896. Corporate insiders own 18.14% of the company’s stock.
Several institutional investors have recently bought and sold shares of MOTS. RTW Investments LP increased its holdings in shares of Motus GI by 672.5% in the fourth quarter. RTW Investments LP now owns 459,478 shares of the company’s stock worth $1,429,000 after buying an additional 400,000 shares during the period. Nantahala Capital Management LLC bought a new stake in shares of Motus GI during the 4th quarter valued at $1,555,000. Perceptive Advisors LLC grew its position in shares of Motus GI by 14.2% during the 4th quarter. Perceptive Advisors LLC now owns 3,210,542 shares of the company’s stock valued at $9,984,000 after acquiring an additional 400,000 shares during the period. Maven Securities LTD bought a new stake in shares of Motus GI during the 4th quarter valued at $167,000. Finally, Spark Investment Management LLC grew its position in shares of Motus GI by 73.5% during the 1st quarter. Spark Investment Management LLC now owns 28,900 shares of the company’s stock valued at $112,000 after acquiring an additional 12,245 shares during the period. 35.30% of the stock is owned by hedge funds and other institutional investors.
Motus GI (NASDAQ:MOTS) last issued its quarterly earnings data on Friday, May 10th. The company reported ($0.29) EPS for the quarter, hitting the consensus estimate of ($0.29). As a group, analysts anticipate that Motus GI will post -1.14 EPS for the current year.
A number of research firms have weighed in on MOTS. Piper Jaffray Companies decreased their price target on Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th. Oppenheimer set a $10.00 target price on Motus GI and gave the stock a “buy” rating in a research note on Thursday, March 28th. Zacks Investment Research downgraded GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. Finally, ValuEngine downgraded Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Motus GI has a consensus rating of “Buy” and an average target price of $8.60.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Recommended Story: What is the formula for the cash asset ratio?
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.